Posted in Life Science Podcast
By: Ayesha Rashid, PhD
In this episode of the Xtalks Life Science Podcast, Ayesha speaks with Stella Sarraf, PhD, CEO and Founder of Spinogenix, a company pioneering novel neurodegenerative therapeutics designed to restore synapses with the potential to reverse cognitive and motor decline in conditions such as ALS, Alzheimer’s disease, schizophrenia and other neurological disorders.
Thank you to Xtalks and host Ayesha Rashid for the opportunity to highlight our science at Spinogenix and discuss how synapse regeneration can impact the lives of many battling neurodegenerative diseases and provide physicians with a new therapeutic modality to help treat their patients.